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Nitric oxide (NO) defends against intracellular patho-
gens, but its synthesis must be regulated due to cell
and tissue toxicity. During infection, macrophages
import extracellular arginine to synthesize NO,
generating the byproduct citrulline. Accumulated
intracellular citrulline is thought to fuel arginine
synthesis catalyzed by argininosuccinate synthase
(Ass1) and argininosuccinate lyase (Asl), which
would lead to abundant NO production. Instead, we
find that citrulline is exported from macrophages
during early stages of NO production with <2% re-
tained for recycling via the Ass1-Asl pathway. Later,
extracellular arginine is depleted, and Ass1 expres-
sion allows macrophages to synthesize arginine
from imported citrulline to sustain NO output. Ass1-
deficient macrophages fail to salvage citrulline in
arginine-scarce conditions, leading to their inability
to control mycobacteria infection. Thus, extracellular
arginine fuels rapid NO production in activated
macrophages, and citrulline recycling via Ass1 and
Asl is a fail-safe system that sustains optimum NO
production.
INTRODUCTION
Mononuclear phagocytes (macrophages and dendritic cells)
recognize, control, and kill a wide variety of pathogens.
Successful pathogens have made corresponding adaptations
to reside and replicate within macrophages (Mycobacterium
sp., Toxoplasma gondii, Leishmania sp.) while other pathogens
use macrophages as a vehicle to facilitate rapid growth and
dissemination (Listeria sp., Salmonella sp., Francisella sp.).
Host containment and killing mechanisms activated after path-Cell Host & Mogen detection include the production of free radical antimicro-
bials, including reactive oxygen species (ROS) and nitric oxide
(NO). NO generation requires inducible nitric oxide synthase
(iNOS) expression through cooperative signals from interferons
and NF-kB activation from TLR and related signaling pathways
(Farlik et al., 2010). The IFN-g-mediated activation of NO pro-
duction is required for control of numerous clinically important
intracellular pathogens in mouse models (Bogdan, 2001; Nathan
and Shiloh, 2000). Furthermore, humans with defects in IFN-g
signaling were discovered due to their increased susceptibility
to Mycobacteria (Casanova and Abel, 2002). In humans, the
production of NO by phagocytes remains controversial because
human macrophages cannot be readily provoked to make NO
in conventional in vitro culture conditions (Martinez et al.,
2006; Vogt and Nathan, 2011). However, both iNOS and NO
have been detected in human tissues and alleles of NOS2
have been linked to M. tuberculosis susceptibility suggesting
that human NO is needed for microbial containment (Choi
et al., 2002; Facchetti et al., 1999; Mo¨ller et al., 2009; Nicholson
et al., 1996; Pautz et al., 2010). Superoxide generation also
contributes to control of M. tuberculosis and to several other
homotropic pathogens (Ehrt and Schnappinger, 2009). Thus,
free radical generation is a critical component of mammalian
resistance to intracellular pathogens.
Macrophages that seed tissues during inflammation can be
‘polarized’ by cytokines, dead cells, and microbial products.
Macrophages adopt M1 (also termed ‘classical’ activation,
driven by TLR and IFN activation) or M2 (‘alternative’ activation,
driven by IL-4 and IL-13 signaling) activation states. M1 and M2
activation is plastic and macrophages can be coerced from one
state to the other depending on the local inflammatory milieu
(Murray and Wynn, 2011a; Stout and Suttles, 2004). In early
work to define macrophage plasticity, arginine metabolism was
recognized to be significant in macrophage biology because
M1 macrophages use arginine to make NO and citrulline while
M2 cells do not express iNOS or produce NO, but instead con-
vert arginine to ornithine and urea via type 1 arginase (Arg1)
(Munder et al., 1998; Shearer et al., 1997). M1 macrophagesicrobe 12, 313–323, September 13, 2012 ª2012 Elsevier Inc. 313
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while M2 macrophages are required for immunity to some
worms and appear critical for wound healing and tissue repair
(Murray and Wynn, 2011b). NO generated from arginine in M1
macrophages is a potent inhibitor of T cell proliferation, an
inducer of necrosis, and a cause of DNA damage, therefore its
levels must be tightly constrained (Bogdan, 2001; Pautz et al.,
2010). Collateral damage from NO production is mitigated in
a myriad of ways. For example, a key pathway to suppress NO
production is the induction of Arg1 expression in M1 macro-
phages, which consumes arginine, limiting the amount available
to iNOS. Some intracellular pathogens have harnessed this
pathway as a survival mechanism by inducing Arg1 in both the
infected and surrounding tissue (El Kasmi et al., 2008; Qualls
et al., 2010).
Arginine is required for nitrogen elimination inmammals via the
urea cycle where toxic ammonia is fixed in the mitochondria of
hepatocytes through the sequential reactions of carbamoyl
phosphate synthase (Cps1) and ornithine transcarbamylase
(Otc). This complex reaction requires ATP, bicarbonate, and
ornithine to generate citrulline. Citrulline is transported out of
the mitochondria and used by argnininosuccinate synthase
(Ass1) and argininosuccinate lyase (Asl) to produce argininosuc-
cinate and arginine, respectively. The urea cycle does not oper-
ate in macrophages because Cps1 and Otc are not expressed.
Instead, macrophages import arginine by cationic amino acid
transporters including CAT1 and CAT2 encoded by Slc7a1 and
Slc7a2, respectively. Whereas CAT1 expression is constitutive,
CAT2 is inducible (Thompson et al., 2008) and is considered to
be the main way activated macrophages harvest arginine from
their environment. Indeed, a threshold concentration of extracel-
lular arginine is required for NO production irrespective of the
amount of arginine inside the cell; this phenomenon is termed
the ‘arginine paradox’ and has yet to be fully explained in
biochemical terms (Lee et al., 2003).
The coordinated expression of iNOS, Ass1, and Asl in acti-
vated macrophages has led to a recycling model for NO
production where the arginine converted to citrulline by iNOS
is recycled to arginine by Ass1/Asl to supply the intracellular
arginine for NO production; a process seemingly at odds with
the ‘arginine paradox’ (Curis et al., 2005; Morris, 2007). Here
we used biochemical methods to uncover advanced aspects
of arginine metabolism in macrophages undergoing parasitism
by intracellular pathogens where NO is required for control.
We first showed that extracellular arginine directly fuels NO
production in M1 activated and infected macrophages while
intracellular arginine levels remain unaltered. Second, when
arginine is plentiful, activated macrophages import this amino
acid and expel citrulline as a byproduct of NO synthesis. Third,
we found that when arginine is depleted following high-output
NO production, citrulline is imported and used to synthesize
arginine via Ass1. Ass1 activity is required for optimal control
of Mycobacteria in both in vitro and in vivo infection models
suggesting that arginine depletion in chronically infected
microenvironments is counteracted by citrulline recycling.
Thus extracellular arginine supports the initial burst of NO,
however, sustained NO production by the conversion of citrul-
line to arginine by Ass1 is necessary for optimal control of
persistent pathogens.314 Cell Host & Microbe 12, 313–323, September 13, 2012 ª2012 ElRESULTS
The Arginine Metabolism Transcriptome
in M1 and M2 Polarization
We first determined the gene expression profile of the known
enzymes and transporters involved in arginine metabolism under
M1 and M2 polarizing conditions (Murray and Wynn, 2011b).
In primary bone marrow-derived macrophages (BMDMs) stimu-
lated with LPS + IFN-g for 24 hr to induce M1 activation as
defined by the pattern of STAT phosphorylation (pSTAT1,
pSTAT3, low or undetectable pSTAT6, Figure 1A), iNOS,
Slc7a2, Arg1, and Ass1 were induced, while Asl, Odc1, and
Oat were repressed (Figures 1B and 1C). M2 polarized macro-
phages, stimulated with IL-4 (pSTAT6, low or undetectable
pSTAT1, pSTAT3, Figure 1A), displayed low NO output coupled
with increased Slc7a2 and Arg1 transcription, but minimal
changes in iNOS, Ass1, Asl, Odc1, and Oat (Figures 1B and
1C). Consistent with the gene expression data, only LPS + IFN-
g stimulation resulted in NO production (Figure S1A), and protein
levels of Asl, Odc1, and Oat remained constant during both M1
and M2 polarization (Figure S1B).
Intracellular Infection Produces Predictable Changes
in the Expression of Genes Encoding Arginine
Metabolizing Enzymes
Whereas the above studies in M1 and M2 polarized macro-
phages gave a clear picture of the expression profiles of mRNAs
encoding arginine metabolizing enzymes, little is known about
the changes that occur in gene expression when macrophages
are parasitized by different intracellular pathogens. Therefore,
we expanded our gene expression analysis to model pathogens
that adopt four distinct intracellular lifestyles (Table 1) (Hingley-
Wilson and Lalvani, 2008; Hybiske and Stephens, 2008; Ray
et al., 2009). Primary macrophages were infected with M. bovis
BCG (Mb BCG), Listeria monocytogenes (Lm), Francisella
tularensis live vaccine strain (Ft LVS), or Chlamydia psittaci
(Cp) over time, followed by gene expression analysis by qRT-
PCR (Figure 1D, bar graphs in Figure S1D). We found that
M. bovis, L. monocytogenes, and F. tularensis induced a distinct
and predictable pattern of gene expression characterized by
early expression of iNOS, Ass1, and Slc7a2 and delayed
expression of Arg1. While macrophages can transport and
metabolize arginine via Slc7a1/CAT1 and Arg2, respectively,
their expression at the mRNA level was unaltered implying
a predominant role for Slc7a2 and Arg1 during these infections
(Figure S1E). Using MyD88-deficient macrophages and a recip-
rocal supernatant transfer assay system, we found that most
gene expression changes could be accounted for by MyD88-
dependent production of host cytokines in combination with
type I IFN signaling (Table 1, Figures 1D, S1F, and S1G).
Although MyD88-deficient macrophages displayed decreased
iNOS mRNA following L. monocytogenes infection, iNOS gene
expression was absent in infected Ifnar/ macrophages
demonstrating the necessity for IFN signaling in this model (Fig-
ure S1H), consistent with previous findings using Ifnb/macro-
phages (Toshchakov et al., 2002). Arg1, while induced following
infection with M. bovis, F. tularensis, and L. monocytogenes, is
regulated by two extrinsic autocrine-paracrine pathways
controlled by MyD88-mediated production of STAT3-activatingsevier Inc.
Figure 1. Transcriptional Regulation of
Arginine Metabolism in Activated Macro-
phages
(A) Left, schematic of M1 and M2 macrophage
polarization. Right, BMDMs were left untreated (-),
or stimulated with LPS + IFN-g, M. bovis BCG +
IFN-g, or IL-4 for the indicated times. Cell lysates
were analyzed by immunoblot.
(B) Predicted model of arginine metabolism in
macrophages.
(C) Left, example transcriptome analysis. Right,
BMDMs (n = 3) were untreated (-) or stimulated
with LPS + IFN-g or IL-4 for 24 hr. RNA was
collected and analyzed by qRT-PCR.
(D) Primary macrophages from C57Bl/6 or
Myd88/ mice were untreated (-) or infected with
M.bovisBCG (n=3,MOI=100),L.monocytogenes
(n = 2, MOI = 10), F. tularensis LVS (n = 3, MOI = 5),
or C. psittaci (n R 2, MOI = 1) for the indicated
times. RNA was collected and analyzed by qRT-
PCR. All panels: Data are representative of at
least two experiments. See also Figure S1.
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Ass1-Dependent NO Production Combats Mycobacteriacytokines (M. bovis, L. monocytogenes; Figure S1I) or MyD88-
mediated production of IL-4 and IL-13 (F. tularensis) (Qualls
et al., 2010; Shirey et al., 2008). C. psittaci, an obligate intracel-
lular pathogen that lives and develops within an inclusion
membrane, caused minimal changes in gene expression of
the arginine metabolizing enzymes suggesting this pathogen
has evolved to induce limited activation of macrophages,
similar to Leishmania sp (Zhang et al., 2010). Collectively, our
data argue that the host response to intracellular infection is
stereotypic and involves activation of arginine transport and
the expression of genes encoding the six regulated arginine
metabolizing enzymes and that this gene expression pattern
is predominantly regulated by host activation of cell extrinsic
pathways that are controlled by MyD88- and IFN-mediated
signaling.
Quantification of Arginine-Derived Metabolites
How gene expression is linked to arginine metabolism was
next investigated using quantitative methodologies to measure
arginine catabolism. The transcriptome data suggested that
macrophages stimulated with LPS + IFN-g or IL-4 should
produce high relative amounts of intracellular citrulline or
ornithine, respectively. To test this, macrophages were leftCell Host & Microbe 12, 313–323, Seuntreated, or stimulated for 24 hr with
LPS + IFN-g or IL-4, and the cell lysates
were subjected to mass spectrometry
(MS) analysis to detect arginine and its
direct metabolites (Figure S2A). Unstimu-
lated BMDMs contained arginine, but
lower amounts of citrulline, ornithine,
and argininosuccinate (Figures 2A and
2B). M1 polarized macrophages had
increased intracellular citrulline at the
expense of arginine, while argininosucci-
nate and ornithine amounts were
modestly increased (Figures 2A and 2B).
Conversely, M2 polarization resulted inan increase in ornithine production, with unchanged citrulline
and argininosuccinate (Figures 2A and 2B).
Citrulline Is Exported from NO-Producing Macrophages
We followed arginine and its metabolites after infection with
M. bovis BCG to explore the arginine metabolic signature during
intracellular infection. M. bovis BCG was chosen as the model
system for themajority of the subsequent studies because unlike
L. monocytogenes, F. tularensis, or M. tuberculosis, BCG does
not induce apoptosis or necrosis in vitro in the time frame of
our experiments, but is still controlled by the host IFN-g-NO
pathway (Hingley-Wilson and Lalvani, 2008; Ramakrishnan,
2012). BMDMs cultured in 13C-arginine as the sole source of
arginine were left untreated, or infected with M. bovis BCG
with and without IFN-g for 24 hr. The peak for 12C-arginine
disappeared and the expected peak for 13C-arginine appeared
when heavy arginine was substituted for normal arginine in the
medium (Figures 2C, 2D, and S2A). BCG-infected BMDMs
contained similar amounts of arginine metabolites as the
unstimulated BMDMs. Only when IFN-g was added did intra-
cellular citrulline increase (Figures 2C and 2D). iNOS-mediated
arginine metabolism results in one molecule of nitric oxide
(NO) plus one molecule of citrulline. Yet, when comparing NOptember 13, 2012 ª2012 Elsevier Inc. 315
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316 Cell Host & Microbe 12, 313–323, September 13, 2012 ª2012 Elproduction to the amount of intracellular citrulline, the estimated
NO output was greater than 100-fold that of intracellular citrulline
(Figures S2B and S2C). Although the Griess assay used to
measure NO production detects NO2
 and not additional NO
derivatives, this estimation of NO output led us to believe that
we were not optimally detecting citrulline production. One
possibility was that following macrophage stimulation and NO
production, citrulline was utilized by Ass1 in arginine recycling,
which would result in continuous NO accumulation. Second,
citrulline may be exported from macrophages following NO
production (Figure S2D).
The contribution of recycling to arginine metabolism was
addressed by culturing BMDMs infected with M. bovis BCG in
media with 15N-arginine the sole source of arginine, resulting in
a fragment ion m/z of 235 for imported arginine and citrulline,
and 234 for recycled arginine. (Figures S2A and S2E). Only
a minute amount of intracellular arginine was derived from the
recycling pathway (Figures 2E and 2F).We next tested if citrulline
was exported frommacrophages following NO production using
radioactive arginine tracing and thin layer chromatography
(TLC). BMDMs, cultured in media containing 3H-arginine, were
stimulated for 24 hr with LPS + IFN-g or with IL-4 as a control.
Arginine metabolites were analyzed from cell lysates and super-
natants. Similar to the data obtained byMS, intracellular citrulline
was increased in LPS + IFN-g stimulated BMDMs compared
to unstimulated and IL-4 stimulated controls (Figures 3A and
3B). However, > 98% of the synthesized citrulline was exported
from macrophages into the extracellular milieu (cell lysate
citrulline = 6.83 102 +/ 0.63 102 cpm, supernatant citrulline =
4.6 3 104 +/ 1.1 3 104 cpm), confirming the preference for
citrulline export versus arginine recycling under these conditions
(Figure 3B). We then determined the kinetics of citrulline export
following stimulation with LPS + IFN-g. As expected there
was a decrease in extracellular arginine over time that began
between 12 and 16 hr post stimulation (Figure 3C). This corre-
lated with an increase in extracellular citrulline and NO that
matched the kinetics of arginine depletion from the media
(Figure 3D). We observed the same trend in IFN-g-stimulated
BMDMs infected with M. bovis BCG (Figure 3E). These data
were verified by MS analysis of citrulline export under the
same stimulation conditions in both BMDMs and thioglycolate
elicited peritoneal-derived macrophages (PDMs) (Figure S3).
Thus, macrophages import extracellular arginine and export cit-
rulline, rather than recycle arginine, for NO production following
pathogenic stimuli or intracellular infection.
Arginine Starvation Primes Macrophages
for Citrulline Metabolism
Ass1 is the enzyme responsible for citrulline metabolism in
mammals (Curis et al., 2005; Morris, 2007). As predicted from
qRT-PCR data, Ass1 protein increased following infection with
M. bovis BCG and was not regulated either by the addition of
IFN-g or the amount of arginine in the media, whereas iNOS
protein production required both BCG and IFN-g (Figure 4A).
Ass1 production following M. bovis BCG infection itself was
not sufficient for NO production, but as expected required
iNOS protein to facilitate the arginine to citrulline reaction
(Figures 4A and 4B). However, during infection with M. bovis
BCG, Ass1 overexpression in RAW 264.7 macrophages wassevier Inc.
Figure 2. Detection of Arginine Metabolites
by Mass Spectrometry
(A and B) BMDMs were untreated (-) or stimulated
with LPS + IFN-g or IL-4 for 24 hr, and cell lysates
were analyzed by mass spectrometry (MS) for
arginine (Arg), citrulline (Cit), argininosuccinate
(Arg-Succ), and ornithine (Orn). Sample mass
spectra are shown (A) with the corresponding
concentrations of indicated metabolites (B).
(C–F) BMDMs were infected with BCG with or
without IFN-g in the presence of heavy 13C-argi-
nine (C and D) or 15N-arginine (E and F) for 24 hr,
and cell lysates were analyzed by MS as above.
The right y axis was used for MS analysis of argi-
ninosuccinate (C and E). Data are representative
of at least three experiments (A and B) or one
experiment (C–F) with BMDMs pooled from at
least four mice. Recycled arginine (Re-Arg). All
panels: Error bars, SEM. See also Figure S2.
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tion compared to vector only controls (Figures 4C and 4D).
We next used conventional Ass1/ mice (Patejunas et al.,
1994). This mutation results in plasma hypercitrullinemia and
death shortly following birth in mice as Ass1 is required in the
urea cycle. We generated fetal liver-derived macrophages
(FLDMs) from Ass1/, Ass1+/, and Ass1+/+ (WT) embryos
and stimulated them with LPS + IFN-g for 24 hr under ‘‘arginine
plentiful’’ concentrations (400 mM) or ‘‘arginine starved’’ condi-
tions (4 mM arginine). While plasma arginine amounts average
100 mM, concentrations in other tissues have not been thor-
oughly examined. We therefore set our experimental conditions
to test two extremes of arginine availability. We found no
differences in NO production between Ass1 and control FLDMs
when arginine was plentiful. However, when citrulline was added
to the low arginine media, WT and Ass1+/ FLDMs displayed
enhanced NO production compared to FLDMs without added
citrulline. FLDMs from Ass1/ mice, on the other hand, failed
to produce more NO when citrulline was added to the media.
Moreover, the effect of citrulline addition on increased NO
production occurred in arginine starved macrophages and not
in arginine plentiful conditions, suggesting citrulline metabolismCell Host & Microbe 12, 313–323, Secontributes to macrophage arginine
biosynthesis and NO production only
under conditions of arginine scarcity
(Figures 4E and 4F).
We next extended our studies to test
the requirement for Ass1 activity during
antimicrobial functions of macrophages.
Under arginine plentiful and starved con-
ditions, FLDMs from Ass1/ and Ass1+/+
controls were infected withM. bovis BCG
without and with the addition of IFN-g
and citrulline. Infection of Ass1+/+ FLDMs
resulted in increased Ass1 protein com-
pared to uninfected FLDMs, and its ex-
pression was not altered further by the
addition of IFN-g or citrulline (Figure 4G).
While some NO was detected from BCGinfection alone, this response was amplified in conditions with
IFN-g (Figure 4H). In arginine plentiful conditions, both Ass1+/+
and Ass1/ FLDMs produced NO following BCG infection.
Whereas Ass1+/+ FLDMs utilize extracellular citrulline to regen-
erate arginine for NO production, Ass1/ FLDMs were unable
to perform this reaction (Figure 4H).
72 hr following infection, macrophage lysates were plated
for BCG growth to determine the effect of added citrulline on
mycobacterial killing. In arginine plentiful conditions, Ass1+/+
FLDMs increased their capacity to kill BCG in the presence
of IFN-g, yet added citrulline had no significant antimicrobial
effect (Figure 4I). Ass1/ FLDMs had less killing capacity, which
correlated with the reduced NO production during infection
(Figures 4H and 4I). In arginine starved cultures there was a
significant increase in killing when extracellular citrulline was
added to the Ass1+/+ FLDMs, yet Ass1/ FLDMs did not
show enhanced killing, consistent with previous data showing
Trypanosoma cruzi can be killed by macrophages when ex-
ogenous citrulline is added to media containing low arginine
(Norris et al., 1995). Similar data were obtained from Ass1-
deficient BMDMs infected with M. bovis BCG (Figures S4A
and S4B), yet Ass1-deficient macrophages infected with eitherptember 13, 2012 ª2012 Elsevier Inc. 317
Figure 3. Citrulline Is Exported from Macrophages Following Inos-
Mediated Arginine Metabolism
(A and B) BMDMs (n = 3) were untreated (-) or stimulated with LPS + IFN-g or
IL-4 in the presence of 3H-arginine for 24 hr. Levels of arginine and its
metabolites were determined by thin layer chromatography (TLC) followed by
scintillation counts per minute (cpm). A sample TLC is shown (A) with the
corresponding relative amounts of intracellular and extracellular arginine and
citrulline (B). Note the difference in scale from the cell lysate and supernatant
graphs. Data are the mean cpm.
(C–E) BMDMs (three mice pooled) were stimulated with LPS + IFN-g or BCG +
IFN-g in the presence of 3H-arginine over time. Extracellular levels of arginine
(C) and citrulline (D and E) were determined by TLC as above. NO production
was determined by assaying supernatant NO2
 (D and E). All panels: Error
bars, SD. See also Figure S3.
Figure 4. Ass1 Regulates NOProduction and Is Required for Optimal
Control of M. Bovis BCG in Arginine-Deprived Macrophages
(A and B) BMDMs (three mice pooled) cultured in media with 400 mM, 4 mM, or
no added arginine, were infected with BCG with and without IFN-g, or left
untreated (-) for 24 hr. Cell lysates were analyzed by immunoblot (A) and NO
production was determined by assaying supernatant NO2
 in duplicate (B).
Data are representative of at least two experiments.
(C and D) RAW 264.7 macrophages overexpressing Ass1 or the vector
backbone (pcDNA3.1) were infected with BCG or left untreated (-) over time. In
(C), overexpression of Ass1 was determined by immunoblot at 48 hr post
treatment. In (D), NO production was determined by assaying supernatant
NO2
. Data are representative of at least two experiments.
(E and F) FLDMs from Ass1+/+ (WT, n = 4), Ass1+/ (n = 8), and Ass1/ (n = 4)
were cultured in media with 400 mM or 4 mM arginine with or without 1mM
citrulline. Macrophages stimulated for 24 hr with LPS + IFN-g (L + g) were
assayed for Ass1 protein by immunoblot (E) and NO production (F). Data are
combined from two experiments.
(G–I) FLDMs from Ass1/ mice or littlermate Ass1+/+ controls (WT) were
cultured in media with 400 mM or 4 mM arginine. FLDMs were infected with
BCG with or without IFN-g for 72 hr in the presence or absence of 1 mM
citrulline. Cell lysates were assayed by immunoblot (G), and NO production
was determined by assaying supernatant NO2
 (H). BCG from lysed macro-
phages were grown for 2–3 weeks on LH10 agar (I). Data from (I) are the BCG
colony forming units (CFU) from individual FLDM lysates of two independent
experiments combined (n = 10). All panels: Error bars, SD. **p < 0.01 by
Student’s t test; ns, not significant. See also Figure S4.
Cell Host & Microbe
Ass1-Dependent NO Production Combats MycobacteriaL. monocytogenes actA/inlB mutant or F. tularensis LVS dis-
played no significant difference in bacterial control compared
to WT macrophages even though they were inhibited in NO
production in low arginine media supplemented with citrulline
(Figures S4C and S4D). While NO is required for optimal control
of mycobacterial infection, conflicting data exist on the necessity
of NO for macrophage control of Listeria and Francisella, likely
reflecting the differences we see in our experiments (Edwards
et al., 2010; Lindgren et al., 2005; MacMicking et al., 1997a;
Nathan and Shiloh, 2000; Polsinelli et al., 1994). Also, we cannot
exclude the possibility of NO-independent mechanisms for
Ass1 function during intracellular pathogenesis in macrophages.
Nevertheless, these data imply that Ass1-mediated citrulline
metabolism is not required for macrophage control of all intra-
cellular pathogen types, thus we focused on the requirement
for Ass1 during mycobacterial infection.
The Ass1 fold mutation is a hypomorphic allele of Ass1 that is
not as severe as the mutation in Ass1/ mice. Ass1fold/fold mice
still succumb to death a few weeks following birth resulting from
pathologies associated with liver and brain dysfunction but
provided us with a convenient experimental tool to establish
bone marrow (BM) chimeras (Perez et al., 2010). Therefore, we
generated chimeric mice by BM transplantation from Ass1+/+
and Ass1fold/fold donors (CD45.2) to lethally irradiated recipient
mice (CD45.1). Greater than 90% chimerism was obtained by
5 weeks post transplant and macrophages from these mice
responded similarly to Ass1/ FLDMs following M1 stimulation
without and with added citrulline (Figures S5A and S5B). As with318 Cell Host & Microbe 12, 313–323, September 13, 2012 ª2012 ElAss1/ FLDMs, 24 hr following M1 stimulation there were no
differences in NO output between WT and Ass1fold/fold macro-
phages (Figure 5A). However, at 48 and 72 hr post stimulationsevier Inc.
Figure 5. Ass1 Is Required for Optimal NO
Output and Control of Infection In Vivo
(A and B) BMDMs from WT or Ass1fold/fold bone
marrow chimeras (n = 3) were cultured in media
with 400 mM, 40 mM, or 4 mM arginine and stimu-
lated for the indicated times with LPS + IFN-g.
Culture supernatants were assayed for NO
production (A) and relative amino acid levels by
MS (B). Data in (B) are from cells cultured in 40 mM
arginine and are normalized to WT arginine levels
equal to 100% at each time point. Error bars, SD.
(C and D) WT and Ass1fold/fold bone marrow
chimeras (n = 6) were infected with an intranasal
dose ofM. bovis BCG containing 2–5 x 105 CFUs.
Four to five weeks following infection, lungs
were analyzed by immunohistochemistry (C) and
homogenized to determine CFUs (D). Data are
representative of three experiments.
(E) WT and Ass1fold/fold bonemarrow chimeras (n =
3 per time point) were infected with an intranasal
dose ofM. bovis BCG containing10 x 106 CFUs.
Lungs were homogenized at the indicated time
points to determine CFUs. Data are from one
experiment. Error bars, SEM.
(F) Model of macrophage NO production via
Ass1-mediated citrulline metabolism. In infected
macrophages, either WT (top) or Ass1-deficient
(bottom) extracellular arginine is preferentially
utilized to generate NO via iNOS, and citrulline is
exported. Over time, arginine becomes limiting,
and WT macrophages utilize Ass1-mediated
citrulline metabolism to regenerate arginine as
a secondary source for NO production—a mech-
anism that is lost in Ass1-deficient macrophages,
resulting in decreased NO levels and increased
bacterial load.
(G and H) WT (n = 5) and Ass1fold/fold (n = 4) bone
marrow chimeras were infected with an aerosol
dose of M. tuberculosis containing 100 CFUs.
Mice were sacrificed 4 weeks post infection
and lungs were analyzed by histology (G) and
homogenized to determine CFUs (H). Data are
from one experiment. All panels: Error bars, SD
(SEM in E). ***p < 0.001, **p < 0.01, *p < 0.05 by
Student’s t test. x p < 0.05 by two-way ANOVA.
See also Figure S5.
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phages were impaired in NO generation when cultured in 40 mM
or 4 mM arginine compared to WT cells, confirming that NO
output from recycled arginine is only required in low extracellular
arginine concentrations (Figure 5A). As expected, citrulline in
supernatants from Ass1fold/fold macrophages was increased
compared to WT since WT macrophages use citrulline for argi-
nine biosynthesis (Figure 5B).
To determine the in vivo role of Ass1 during infection, we intra-
nasaly infected WT and Ass1fold/fold BM chimeras with M. bovis
BCG. Mice showed no clinical symptoms of distress while in-
fected. Mice were euthanized 4–5 weeks following infection
and displayed lung pathology associated with infection, yet
Ass1fold/fold chimeras had increased inflammation and macro-
phage F4/80 staining compared to WT (Figures 5C and S5C–
S5E). Most striking was that in the macrophage rich areas,
Ass1fold/fold chimeras had reduced ability to produce NO to theCell Host & Msame degree as in WT as determined by nitrotyrosine staining
(Figures 5C and S5F). Proper regulation of NO production is
required for optimal control of mycobacteria in vivo (El Kasmi
et al., 2008; MacMicking et al., 1997b), so we tested whether
Ass1fold/fold chimeras are impaired in controlling BCG. Lungs
from chimera mice infected with M. bovis BCG were homoge-
nized and plated to determine CFUs (Figure 5D). Ass1fold/fold
chimeric mice were significantly impaired at controlling
M. bovisBCG, supporting the key role for NO in regulatingmyco-
bacterial infection. We expanded these experiments to test the
the efficiency of mycobacterial clearance. Mice were infected
with a high dose of M. bovis BCG, and lung CFUs were deter-
mined across time. While WT and Ass1fold/fold BM chimera
mice displayed decreased mycobacterial loads across time,
Ass1fold/fold mice were significantly slower in clearing BCG
compared to WT (Figure 5E). Data from these experiments
lead to the model depicted in Figure 5F, in which we imply theicrobe 12, 313–323, September 13, 2012 ª2012 Elsevier Inc. 319
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production and optimal control of M. bovis BCG under arginine
scarcity. We next tested this model during virulent
M. tuberculosis infection. WT and Ass1fold/fold bone marrow
chimeras were infected with an aerosol dose of M. tuberculosis
and lungs were analyzed for pathology and CFUs 4 weeks
post infection. As with BCG infection there were no obvious clin-
ical differences between WT and Ass1fold/fold mice during the
course of infection, however, Ass1fold/fold mice displayed
increased lung inflammation combined with decreased infection
control (Figures 5G and 5H).
DISCUSSION
Macrophage activation stimulates arginine import, which fuels
the initial burst of NO synthesis to suppress intracellular patho-
gens consistent with older studies performed on the CAT2
system (Mori and Gotoh, 2000). Concurrent to arginine import
and oxidation to NO, we found that citrulline is exported during
the early stages of NO biosynthesis from arginine rather than
being used to regenerate arginine. As time progresses, arginine
is depleted from the milieu and citrulline import followed by its
conversion to arginine by Ass1 and Asl is required to sustain
NO biosynthesis. Thus, we concluded that Ass1/Asl expression
functions as a fail-safe system to sustain NO production in the
event extracellular arginine is depleted from the environment.
In the absence of Ass1 activity, the initial phase of NO synthesis
is supported by extracellular arginine, but the resulting citrulline
cannot be scavenged from the environment to sustain NO
production for longer periods of time (Figure 5F). The early induc-
tion of Ass1 following macrophage activation suggests that the
switch from arginine to citrulline utilization for NO production
may be frequently encountered in tissue microenvironments
where pathogens are encountered. The impaired pathogen
control in the Ass1fold/fold chimeric mice provide compelling
in vivo data to support this idea, but critically testing this concept
bymeasuring intracellular and extracellular arginine and citrulline
concentrations within restricted host microenvironments will
require high-resolution MS tissue imaging capabilities that are
in the early stages of development.
Four separate intracellular infections—M. bovis BCG,
F. tularensis LVS, L. monocytogenes, and C. psittaci—induce
the arginine metabolism transcriptome in macrophages to
varying degrees, yet one commonality present in all infection
types was the pattern of Ass1 induction (Figures 1 and S1).
These data suggest that macrophages prime for arginine recy-
cling early during infection to prepare for limiting extracellular
arginine. This type of regulation would be expected for a gene
involved in the antimicrobial response. Consistent with this
idea, multiple studies have separated LPS-induced genes in
macrophages as either ‘‘tolerizeable’’ (genes turned off following
extensive LPS stimulation) or ‘‘nontolerizeable’’ (genes remain-
ing elevated, or further induced following extensive LPS stimu-
lation) (Foster et al., 2007; Henricson et al., 1993). Ass1 was
classified as nontolerizeable by Foster et al., suggesting its
importance in prolonged exposure to microbial products or
infection. Even though Ass1 expression is induced via TLR
stimulation and M. bovis BCG infection, arginine recycling
does not occur in substantial amount during the first 24 hr320 Cell Host & Microbe 12, 313–323, September 13, 2012 ª2012 Elwhen extracellular arginine is readily available (Figure 2), and
citrulline produced from iNOS is exported following its formation
(Figure 3), similar to that observed in rat alveolar macrophages
(Hammermann et al., 1998).
Citrulline detection in culture supernatants frommacrophages
stimulated with TLR ligands was reported over two decades
ago (Benninghoff et al., 1991; Hibbs et al., 1988), and shortly
thereafter citrulline conversion into arginine at the cellular level
was described in primary rat macrophages (Wu and Brosnan,
1992). Also from this time the initial gene regulation of Ass1
and Asl following inflammatory stimuli and TLR ligation in primary
macrophages and macrophage cell lines was described (Mori,
2007; Nussler et al., 1994). Aside from a key report from Norris
and colleagues, which showed that media citrulline accounted
for NO-dependent killing of Trypanosoma cruzi parasites (Norris
et al., 1995), little work has been performed to connect arginine
recycling and pathogenesis in macrophages in vitro or in vivo.
Why do activated macrophages expel citrulline? There are
several plausible answers to this question. First, in macrophages
generating high amounts of NO, citrulline could act as a feedback
inhibitor of iNOS and thereby reduce the efficiency of the
enzyme. Expelling citrulline from the cell would remove the
inhibitor and potentially allow faster conversion of arginine to
NO. To our knowledge this facet of iNOS enzymology has not
been documented in kinetic assays using purified protein.
However, most NOS inhibitors are chemical variants of arginine
and citrulline. A second possibility is that citrulline is expelled to
return to the liver for shunting into the urea cycle. Alternatively,
citrulline may be toxic to other macrophage cellular processes
or components. However, this seems unlikely given that
macrophages reimport and metabolize citrulline once arginine
becomes limiting. T cells also utilize extracellular citrulline to
sustain proliferation during arginine starvation, suggesting inter-
cellular sharing of this amino acid between macrophages and
lymphocytes (Bansal et al., 2004). Full resolution of the citrulline
export problem will first require the identification of the mecha-
nisms involved in transport of citrulline to the extracellular milleu.
While citrulline transport has been examined previously, no
exclusive citrulline transporter has been identified. Instead, entry
of citrulline occurs via broad neutral amino acid soluble carriers
that are highly tissue specific (Curis et al., 2005; Hediger et al.,
2004). Macrophages use both sodium-dependent and -indepen-
dent transporters for citrulline import (Baydoun et al., 1994), yet
whether citrulline export utilizes a similar set of transporters, or if
an exclusive citrulline transporter exists in macrophages is yet
to be determined.
We anticipated that macrophages with modified Ass1 would
display altered citrulline metabolism because the only known
enzyme that utilizes citrulline in mammalian cells is Ass1 (Curis
et al., 2005; Morris, 2007). Overexpression of Ass1 in RAW
264.7 cells increased NO production, even in arginine-rich
media, demonstrating that Ass1 protein levels affect arginine
biosynthesis in macrophages. Conversely, genetic ablation of
Ass1 had little effect on NO production in primary macrophages
in arginine plentiful conditions, yet Ass1-deficient macrophages
were unable to produce NO in arginine starved conditions
when citrulline was present in the media (Figure 4). This loss of
arginine biosynthesis was relevant during infection because
Ass1-deficient FLDMs and BMDMs were less able to controlsevier Inc.
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that Ass1 activity was critical during lung infection withM. bovis
BCG by showing that Ass1fold/fold bone marrow chimeras
produced stunted levels of NO, determined in vitro and by
nitrotyrosine staining on lung sections, and were impaired at
suppressing M. bovis BCG. Finally, we established the require-
ment for Ass1 during virulent M. tuberculosis infection as
Ass1-deficient mice were significantly impaired at controlling
infection compared to WT mice (Figure 5). These data suggest
an opportunity for molecular targeting as a form of therapy in
mycobacteria-infected patients. We speculate the upregulation
of Ass1, or possibly Asl, in alveolar macrophages in conjunction
with current antituberculosis therapy may allow increased NO
production and assist in controlling M. tuberculosis.
EXPERIMENTAL PROCEDURES
In Vitro Pathogen/Macrophage Cocultures
BMDMs or thioglycollate elicited PDMs were prepared and infected in vitro
with M. bovis bacillus Calmette-Gue´rin Pasteur strain (Mb BCG), Listeria
monocytogenes LO28 (Lm), Francisella tularensis live vaccine strain (Ft LVS),
and Chlamydia psittaci (Cp) as described (Miyairi et al., 2007; Qualls et al.,
2010; Reutterer et al., 2008; Shirey et al., 2008). Reciprocal supernatant trans-
fers: Sterile supernatants from the above infections were used to stimulate
BMDMs from C57Bl/6 orMyd88/mice. FLDMs were obtained by collecting
livers fromAss1+/+,Ass1+/, andAss1/ embryos at E14 and culturing them in
L-cell conditioned media for 5–6 days. For killing assays, Mb BCG-macro-
phage cocultures were washed with PBS, and cell lysates were prepared in
1 ml PBS + 0.25% Tween 20. Lysates received four, 30 s-rounds of sonication
at 25–30 W, and 200 ml of the sonicate was plated on OADC enriched 7H10
Middlebrook agar plates. CFUs were counted following 12 to 16 days incuba-
tion at 37C + 5% CO2. Macrophage stimulant concentration: E. coli LPS
(100 ng/ml, Sigma), IFN-g (2 ng/ml, BD Biosciences), and IL-4 (10 ng/ml, BD
Biosciences).
In Vivo Mycobacterial Infection
M. bovis BCG was administered intranasally in a 50 ml inoculum. Tissues were
analyzed 4–13 weeks post infection. Lungs were homogenized in PBS and
plated in 10-fold serial dilutions on 7H10 Middlebrook agar plates supple-
mented with OADC. CFUs were counted following 2.5 weeks incubation at
37C. Lungs from some mice were inflated with 10% buffered formalin for
histology. A low dose aerosol infection with Erdman M. tuberculosis (Trudeau
Institute) was performed using a whole body inhalation exposure system
(Glas-Col, Terre Haute, IN) that routinely yields 100 CFU day 1 post infection.
At 4 weeks post infection, the animals were sacrificed and the right superior
lobe of the lung was homogenized in PBS containing 0.05% Tween-80. Serial
dilutions of the homogenates were plated onto 7H11 agar. The plates were
incubated at 37C, and colonies were counted after 21 days. For histopatho-
logical analysis, the left lung lobe was fixed in 4% paraformaldehyde and
paraffin embedded until further processing.
Mass Spectrometry
Cell and Supernatant Preparation
Intracellular: 103 106 to 153 106 BMDMswere plated on 10 cm tissue culture
dishes in C-DMEM and stimulated as described in the text. Cells were washed
twice with cold PBS on ice and lysed with 1 ml cold methanol per plate. Cell
debris was pelleted, and methanol supernatants were collected. Extracellular:
0.5 3 106 to 1.5 3 106 BMDMs or PDMs were stimulated as described in the
text. Supernatants were collected and mixed with methanol (1:1, v/v). [U-13C]-
and [U-15N]-Arginine were obtained from Cambridge Isotope Laboratories,
Inc. (Andover, MA).
Preparation of Butyl Esters of Amino Acids
Methanol from the samples was evaporated, and the residue was resus-
pended in 300 ml of 100% ethanol. Ethanol was evaporated, and the amino
acid butyl esters were made (Johnson, 2001). The residue was resuspendedCell Host & Min 200 ml of n-Butanol /3N hydrogen chloride. The mixture was heated at
65C for 15 min and evaporated. Solvents were evaporated by speed-vac
(Savant). The residue was dissolved in 400 ml of acetonitrile/water/formic
acid (50:50:0.1, v/v/v). The sample was filtered through a 0.22 mm syringe filter
and stored at 4C until further use. For mass spectrometry (MS) the samples
were diluted 1:10 in methanol/water (50:50, v/v). Propyl ester of arginine and
heavy arginine were used as internal standards at 300 nM final concentration.
Thesewere prepared similar to the butyl ester except n-Propanol/3N hydrogen
chloride was used to make the ester.
Electrospray Ionization and Tandem MS
MS data was obtained using a Thermo Finnigan TSQ Quantum Ultra triple
quadrupole mass spectrometer (Thermo Fisher Scientific). Analysis was
carried out in the positive ESI selected reaction monitoring (SRM) mode with
unit resolutions at both Q1 and Q3 set at 0.70 full width at half maximum.
A parent scan for the product size of 70 was done for the light arginine and
74 for the heavy arginine experiments. The parent compounds analyzed
were ornithine, arginine, citrulline, and argininosuccinic acid (for MS parame-
ters, see Supplemental Experimental Procedures). The data were acquired
and analyzed using QuantumTune software version 1.2 (Thermo Fisher
Scientific). Data were analyzed by calculating the area under the curve of the
ion current peaks of the internal standard and sample.
Thin Layer Chromatography
Macrophages were grown in DMEM media with 10% FBS supplemented with
400 mMarginine (containing 40 mCi 3H-arginine) and stimulated with LPS + IFN-
g or IL-4. Cells were lysed in methanol, evaporated to dryness in a speedvac
and resuspended in 10 ml of 50% methanol-water (v/v). The neat supernatant
and the cell fraction were spotted on preactivated Silica gel-G plates. Thin
layer chromatography (TLC) plates were developed with chloroform: meth-
anol: ammonium hydroxide: water (1:4:2:1 v/v/v/v). For the time course exper-
iments with 3H-arginine the supernatants were dried and made into butyl
esters as described above. Samples were resuspended in 25 ml of methanol:
water (50:50 v/v) and 5 ml was spotted on Silica gel-G plates. The TLC was
developed with chloroform: methanol: ammonium hydroxide (3:1:0.02 v/v/v).
Standards of arginine, citrulline, and ornithine were run in parallel along with
the samples and detected by spraying with ninhydrin for all TLC experiments.
Radioactive arginine derivatives in the TLC plates were detected using a radio-
TLC Imaging Scanner (Bioscan AR-2000), scanning for 10 min per lane.
RNA Analysis
RNA was collected using Trizol (Invitrogen) or TriPure (Roche). cDNA was
synthesized using SuperScript II reverse transcriptase (Invitrogen) and
analyzed by qRT-PCR. Data are presented as the mean amplicon values
normalized to Gapdh and presented as fold change to untreated.
Cell Culture with Defined Arginine
Dulbecco’s Modified Eagle’s Medium (DMEM) lacking arginine, leucine, and
lysine (Sigma, D9443) was supplemented to nutrient levels in standard
DMEM (Mediatech, 10-013-CV) used for cell culture. Arginine was supple-
mented at either 400 mM, 40 mM, or 4 mM as needed. Media was made
‘‘complete’’ by adding 10% dialyzed fetal bovine serum (GIBCO, 26400) which
lacked additional arginine. Arginine in the media were verified by mass
spectrometry.
NO and Urea Production
Nitric oxide production was determined my measuring supernatant NO2
with
Greiss reagent. Titrated sodium nitrite was used as a standard. Urea produc-
tion (QuantiChrom Urea Assay Kit, BioAssay Systems USA) was not assayed
as extracellular citrulline inhibited urea detection (Figure S1C).
Ass1 Overexpression in RAW 264.7 Cells
1 3 107 RAW 264.7 cells mixed with either 20 mg pcDNA3.1 (empty vector) or
20 mg pcDNA3.1 containing Ass1 cDNA were electroporated at 975 mF, 320 V.
RAW 264.7 cell lines stably expressing these vectors were generated by
growing in selection media (C-RPMI) containing 200 mg/ml hygromycin
B. Colonies surviving hygromycin B selection were used in cell culture as
described in the text, and Ass1 overexpression was determined by
immunoblot.icrobe 12, 313–323, September 13, 2012 ª2012 Elsevier Inc. 321
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Protein lysates were separated by Tris-HCl buffered 4%–15% gradient SDS
PAGE, followed by transfer to Protran membrane. Membranes were blocked
in 3% milk in Tris-buffered saline plus 0.05% Tween and immunoblotted for
respective proteins (see Supplemental Experimental Procedures). Histology
sections were stained by the St. Jude Veterinary Pathology Core using hema-
toxylin and eosin, standard staining for acid fast bacilli, and immunohisto-
chemistry using antibodies against F4/80, CD3, B220 and nitrotyrosine.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with this article
online at http://dx.doi.org/10.1016/j.chom.2012.07.012.
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